BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 7517653)

  • 1. Adenovirus-mediated in vivo gene transfer.
    Brody SL; Crystal RG
    Ann N Y Acad Sci; 1994 May; 716():90-101; discussion 101-3. PubMed ID: 7517653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Rosenfeld MA; Chu CS; Seth P; Danel C; Banks T; Yoneyama K; Yoshimura K; Crystal RG
    Hum Gene Ther; 1994 Mar; 5(3):331-42. PubMed ID: 7517189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for the respiratory manifestations of cystic fibrosis.
    Korst RJ; McElvaney NG; Chu CS; Rosenfeld MA; Mastrangeli A; Hay J; Brody SL; Eissa NT; Danel C; Jaffe HA
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S75-87. PubMed ID: 7533609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
    C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses.
    Imler JL; Bout A; Dreyer D; Dieterlé A; Schultz H; Valerio D; Mehtali M; Pavirani A
    Hum Gene Ther; 1995 Jun; 6(6):711-21. PubMed ID: 7548271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
    Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
    Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Brody SL; Metzger M; Danel C; Rosenfeld MA; Crystal RG
    Hum Gene Ther; 1994 Jul; 5(7):821-36. PubMed ID: 7526901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety.
    Bout A; Imler JL; Schultz H; Perricaudet M; Zurcher C; Herbrink P; Valerio D; Pavirani A
    Gene Ther; 1994 Nov; 1(6):385-94. PubMed ID: 7584104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro.
    Zabner J; Couture LA; Smith AE; Welsh MJ
    Hum Gene Ther; 1994 May; 5(5):585-93. PubMed ID: 7519884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
    Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
    Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
    [No Abstract]   [Full Text] [Related]  

  • 12. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
    Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
    Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
    Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
    Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.
    Crystal RG; Jaffe A; Brody S; Mastrangeli A; McElvaney NG; Rosenfeld M; Chu CS; Danel C; Hay J; Eissa T
    Hum Gene Ther; 1995 May; 6(5):643-66. PubMed ID: 7578401
    [No Abstract]   [Full Text] [Related]  

  • 15. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans.
    Grubb BR; Pickles RJ; Ye H; Yankaskas JR; Vick RN; Engelhardt JF; Wilson JM; Johnson LG; Boucher RC
    Nature; 1994 Oct; 371(6500):802-6. PubMed ID: 7523956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.
    Hay JG; McElvaney NG; Herena J; Crystal RG
    Hum Gene Ther; 1995 Nov; 6(11):1487-96. PubMed ID: 8573621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.
    Mastrangeli A; Harvey BG; Yao J; Wolff G; Kovesdi I; Crystal RG; Falck-Pedersen E
    Hum Gene Ther; 1996 Jan; 7(1):79-87. PubMed ID: 8825871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of cyclic adenosine monophosphate-stimulated chloride channel activity in human cystic fibrosis tracheobronchial submucosal gland cells by adenovirus-mediated and cationic lipid-mediated gene transfer.
    Jiang C; Finkbeiner WE; Widdicombe JH; Fang SL; Wang KX; Nietupski JB; Hehir KM; Cheng SH
    Am J Respir Cell Mol Biol; 1999 Jun; 20(6):1107-15. PubMed ID: 10340929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioisotopic imaging allows optimization of adenovirus lung deposition for cystic fibrosis gene therapy.
    Lerondel S; Le Pape A; Sené C; Faure L; Bernard S; Diot P; Nicolis E; Mehtali M; Lusky M; Cabrini G; Pavirani A
    Hum Gene Ther; 2001 Jan; 12(1):1-11. PubMed ID: 11177537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.
    Yei S; Mittereder N; Wert S; Whitsett JA; Wilmott RW; Trapnell BC
    Hum Gene Ther; 1994 Jun; 5(6):731-44. PubMed ID: 7948135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.